View this email in your browser

June 2020

6th IPCRG Clinical Practice Webinar & Abstract Presentations

COVID-19 & Diagnosis and Management of COPD in Primary Care
  Saturday 20 June 2020, 1000-1200hrs BST

Our topic this week covers COVID-19 & the Diagnosis and Management of COPD in Primary Care. We are delighted to welcome our speakers Professor Hilary Pinnock and Dr Vince Mak.
Professor Hilary Pinnock, Professor of Primary Care Respiratory Medicine, The University of Edinburgh, General Practitioner, Whitstable Medical Practice and immediate past Chair of IPCRG Education committee
Dr Vince Mak, NHS London Clinical Director for Respiratory Strategic Clinical Network, Executive Committee Member of our UK group, PCRS, and an active member of our Asthma Right Care movement.
Over recent years, the trend to diagnose and manage chronic obstructive pulmonary disease (COPD) in primary care has increased.  However, there remains significant national variation in what is expected, encouraged or feasible. This is now more complex with COVID-19.   This webinar will provide an update on how primary care can diagnose and support the management and palliation of COPD in different settings. It will include organisation of care, remote consultations, feasible diagnostic and assessment tests during COVID-19, helping people quit smoking, assessment and management of exacerbations, prescribing, admission criteria, options for pulmonary rehabilitation and managing co-morbidities.
Our plenary talks are followed by some of the most highly ranked abstracts that were selected for presentation at the 10th IPCRG World Conference which has been postponed for a year. These webinars are helping researchers share their work with an international audience and gain important peer review that otherwise might have been missed during the current pandemic.

Register at:
Please note the minor amendment to programme order and titles for our webinar on Saturday.
Programme, Saturday 20 June 2020
Timing BST
Welcome Amanda Barnard, Chair, IPCRG Education Sub Committee 1000-1005
Plenary Speaker 1 COVID-19 & Diagnosis and Management of COPD in Primary Care
(Presentation will include risk, organisation of care, managing co-morbidities, rehabilitation, maintaining essential respiratory care, top tips) Hilary Pinnock, UK
Plenary Speaker 2 COVID-19 & Diagnosis and Management of COPD in Primary Care (Presentation will include organisation of care, tests, exacerbation management, admission criteria, top tips) Vince Mak, UK 1020-1035
  Discussion with Q&A 1035-1050
Video & Comfort Break
Oral Abstracts
  1. Practices and perceptions of primary care physicians in rural India for diagnosis and management of asthma and COPD:  a mixed methods study - Dhiraj Agarwal, India
  1. A comparison of the provision of Specialist Palliative Care to a cohort of patients with GOLD Stage D COPD, 2014 and 2016 Ciara Hanrahan, Ireland
  1. Formulating and testing a strategy for introducing Pulmonary Rehabilitation for COPD management in a rural Indian setting          Harshpreet Kaur, India
  1. A randomized controlled feasibility trial (RCT) of a pulmonary rehabilitation (PR) programme for symptomatic COPD Patients in Georgia: A Breathe Well study Mariam Maglakelidze, Georgia
  1. Predicting hospitalization of Swedish patients due to COPD exacerbation with machine learning Karin Lisspers, Sweden
  1. Spirometry network at the primary health care level in Kyrgyzstan: first experience, lessons and prospects Talant Sooronbaev, Kyrgyzstan
Close Amanda Barnard, Chair, IPCRG Education Sub Committee 1200-1205
All the resources from previous IPCRG webinars, including the presentations and session recordings, can be found by following the links below:
16 May COVID-19 in Primary Care: Supporting those Suffering & Recovering Presenters: Steve Holmes, UK & Matthieu Bremond, France
23 May COVID-19 in Primary Care: Supporting People’s Mental Health Presenters: Lindsay Ip, UK & Jaime Correia de Sousa, Portugal
30 May COVID-19 in Primary Care: Protecting the Most Vulnerable Presenters: Hanna Sandelowsky, Sweden & Chunhua Chi, China
6 June COVID-19 & the Primary Care Management of Asthma Presenters: Dermot Nolan, Ireland & Alan Kaplan, Ireland
13 June COVID-19 & the Challenges of Diagnosing Asthma in Primary Care Presenters: Luke Daines, UK & Jim Stout, USA
IPCRG also has frequently updated resources on many aspects of COVID-19. These can be accessed by following this link: There are a wide variety of resources including:
  • Expert Recommendations for the Prevention and Control of COVID-19 Infections in Primary Care (First Edition)
  • Handbook on COVID-19 Infection, Prevention and Control in Communities: Compiled and published by the Bureau of Disease Prevention and Control of National Health Commission of People’s Republic of China
We only have 2 webinars left in this seriesTimings and topics are below. Book your place here.
27 June 1200-1400 BST COVID-19, Tobacco Dependence & Chronic Lung Disease (Asthma, COPD, ACOS) in Primary Care, Presenters: Noel Baxter & Darush Attar-Zedah, UK
04 July 1500-1700 BST COVID-19 & the Importance of Public Education in Primary Care
Presenters: Sundeep Salvi, India & Javiera Corbalán, Chile
Registration for the webinars for all healthcare professionals is free and open to the primary care respiratory academic community and all respiratory interested primary care healthcare professionals.
IPCRG would like to express their appreciation to Astra Zeneca for supporting this webinar:
Respiratory & Immunology is one of AstraZeneca’s three therapy areas and is a key growth driver for the Company.
AstraZeneca is an established leader in respiratory care, and its inhaled and biologic medicines reached more than 53 million patients in 2019. Building on a 50-year heritage, the Company aims to transform the treatment of asthma and COPD by focusing on earlier biology-led treatment, eliminating preventable asthma attacks, and removing COPD as a top-three leading cause of death. The Company’s early respiratory research is focused on emerging science involving immune mechanisms, lung damage and abnormal cell repair processes in disease and neuronal dysfunction.

With common pathways and underlying disease drivers across respiratory and immunology, AstraZeneca is following the science from chronic lung diseases to immunology-driven disease areas. The Company’s growing presence in immunology is focused on five mid- to late-stage franchises with multi-disease potential, in areas including rheumatology (including lupus), dermatology, gastroenterology, and systemic eosinophilic-driven diseases. AstraZeneca’s ambition in Respiratory & Immunology is to achieve disease modification and durable remission for millions of patients worldwide.
Go to to find out more about the IPCRG, a charity  working locally in primary care and collaborating globally to improve respiratory health so that we can achieve our vision of a global population breathing and feeling well through universal access to right care.
With our best wishes,
Ioanna Tsiligianni               
President IPCRG             

Siân Williams
The International Primary Care Respiratory Group (IPCRG) is a charity registered in Scotland working internationally (SC No: 035056) and a company limited by guarantee (Company number 256268)
The IPCRG is the Respiratory Special Interest Group of WONCA Europe and an Organisation in Collaborative Relations with WONCA Global 

The IPCRG is the primary care representative on WHO-Global Alliance against Chronic Respiratory Diseases (GARD) Planning Executive

Supporter of the NCD Alliance
Copyright © 2020 IPCRG, All rights reserved.

Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.